SPY306.57+1.02 0.33%
DIA256.90+1.63 0.64%
IXIC9,565.96+13.91 0.15%

AMAG Pharmaceuticals Q1 EPS $(0.720) Misses $(0.030) Estimate, Sales $68.661M Beat $64.820M Estimate

AMAG Pharmaceuticals (NASDAQ:AMAG) reported quarterly losses of $(0.720) per share which missed the analyst consensus estimate of $(0.030) by 2300 percent. This is a 20 percent increase over losses of $(0.900) per share

Benzinga · 05/11/2020 11:17

AMAG Pharmaceuticals (NASDAQ:AMAG) reported quarterly losses of $(0.720) per share which missed the analyst consensus estimate of $(0.030) by 2300 percent. This is a 20 percent increase over losses of $(0.900) per share from the same period last year. The company reported quarterly sales of $68.661 million which beat the analyst consensus estimate of $64.820 million by 5.93 percent. This is a 9.42 percent decrease over sales of $75.804 million the same period last year.